FAST REVISION
Pharmacology
Oprelvekin (Interleukin 11) is the only agent approved by the FDA for treatment of thrombocytopenia secondary to myelosuppressive cancer chemotherapy
Filgrastim (G-CSF) and Sargramostim (GM-SCF) are used in the treatment of neutrope
General Microbiology
Type VII bacteriophage types of diphtheria bacilli are associated with avirulent strains.